Detalles de la búsqueda
1.
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.
Circulation
; 141(18): 1463-1476, 2020 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237898
2.
Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
J Lipid Res
; 60(8): 1425-1431, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133557
3.
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
Eur J Clin Invest
; 48(2)2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29178180
4.
High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Arterioscler Thromb Vasc Biol
; 37(1): 118-129, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27879252
5.
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Arterioscler Thromb Vasc Biol
; 37(6): 1194-1205, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28385702
6.
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
J Cell Mol Med
; 20(6): 1170-81, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26990127
7.
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
Anal Bioanal Chem
; 407(28): 8533-42, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26377937
Resultados
1 -
7
de 7
1
Próxima >
>>